Shares of Tempur Sealy (TPX) were lower Wednesday after the company said that sales for the current quarter will be below its prior estimates. The mattress company now says it expects sales for the year to decline between 1% to 3% from the same period last year. It also reduced its full-year outlook for adjusted EBITDA to be between $500 million and $525 million, which is lower than its previous forecast. Analysts with Longbow subsequently downgraded the stock to NEUTRAL from BUY, and Piper Jaffray cut its price target to $63 from $84.
More from Video
Conagra Brands Looks Tastier After Its Upgrade to Buy
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Biogen Bulls Get a Lift From Quant Upgrade and Strengthening Charts
Breaking down an approach to the long side of this biotech stock.
Is Renewable Energy the Defensive Stock Opportunity You're Missing
AMSC CEO discusses that and China challenges.
Takeda Pharmaceutical CEO Talks Big Pharma Trends
One of pharma's biggest CEO's talks M&A action on the exchange.
Real Money Video Wrap: Citi Surges as View of Stability Saves Sentiment
Citi overcame a mixed print to send its stock surging on Monday.
Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation.
If you have questions, please contact us here.